Filing Flows › Xylem (XYL) › Guidance history
Xylem (XYL) guidance history: what it guided and what it reported
Xylem gave guidance in 12 earnings releases on file since Feb 6, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.6% against the guided midpoint. Its releases raised guidance 5 times and lowered it once.
Revenue
Met or beat 2 of 2 periods (0 above, 2 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $9.1B–$9.2B (Feb 10, 2026) → raised $9.2B–$9.3B (Apr 28, 2026) → lowered $9.2B (Jul 28, 2026) → lowered $8.9B (Oct 27, 2026) | — | to be reported | — |
| FY2025 | $9.0B (Oct 28, 2025) | $9.0B | within the range | +0.4% |
| FY2024 | $8.4B–$8.5B (Feb 6, 2024) → raised $8.5B (May 2, 2024) → raised $8.6B (Jul 30, 2024) → lowered $8.5B (Oct 31, 2024) | $8.6B | within the range | +0.7% |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $5.35–$5.60 (Feb 10, 2026) → reaffirmed $5.35–$5.60 (Apr 28, 2026) → raised $5.55–$5.70 (Jul 28, 2026) → lowered $5.40–$5.45 (Oct 27, 2026) | — | to be reported | — |
| FY2025 | $4.50–$4.70 (Feb 4, 2025) → reaffirmed $4.50–$4.70 (Apr 29, 2025) → raised $4.70–$4.85 (Jul 31, 2025) → raised $5.03–$5.08 (Oct 28, 2025) | — | — | — |
| FY2024 | $4.00–$4.20 (Feb 6, 2024) → raised $4.10–$4.25 (May 2, 2024) → raised $4.18–$4.28 (Jul 30, 2024) → reaffirmed $4.22–$4.24 (Oct 31, 2024) | — | — | — |
Adjusted EBITDA margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 22.9%–23.3% (Feb 10, 2026) → reaffirmed 22.9%–23.3% (Apr 28, 2026) → raised 23.1%–23.5% (Jul 28, 2026) → lowered 23.2% (Oct 27, 2026) | — | to be reported | — |
| FY2025 | 21.3%–21.8% (Feb 4, 2025) → reaffirmed 21.3%–21.8% (Apr 29, 2025) → reaffirmed 21.3%–21.8% (Jul 31, 2025) → raised 22.0%–22.3% (Oct 28, 2025) | — | — | — |
| FY2024 | 19.4%–19.9% (Feb 6, 2024) → raised 20.0% (May 2, 2024) → reaffirmed 20.0% (Jul 30, 2024) → raised 20.5% (Oct 31, 2024) | — | — | — |
The latest quarter
Xylem, Q3 2026: revenue $2.2B (-3% year over year), operating margin 17.5%, net earnings $291M, operating cash flow $331M. The chart follows the revenue to costs, profit and cash.
Questions
Does Xylem beat its guidance?
Xylem gave guidance in 12 earnings releases on file since Feb 6, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.6% against the guided midpoint.
How often does Xylem raise guidance?
Its earnings releases raised guidance 5 times and lowered it once since Feb 6, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.